
About this Episode
A new treatment for post-traumatic stress disorder has reported encouraging results, offering a potential new option for people who have not found relief through existing therapies.
The treatment, called Magnetic e-Resonance Therapy (MeRT), combines brain mapping with magnetic stimulation. Doctors first use an electroencephalogram (EEG) to measure electrical activity in the brain, then tailor magnetic pulses to the individual’s brain patterns.
In a clinical trial, the company behind the technology reported a 52% reduction in PTSD symptoms, with 68% of participants reaching remission. The treatment involves five sessions a week over five to six weeks.
The US Food and Drug Administration cleared the MeRT system for PTSD in June 2026, making it a new non-medication option. The approach could be particularly valuable for patients who struggle with medication side effects or have not benefited enough from existing care.
There is, however, an important caveat: the full results behind the reported figures have not yet been publicly published, so further independent scrutiny is needed. FDA clearance also does not mean the treatment will work for everyone.
Still, personalised brain stimulation represents a promising new direction in mental healthcare, where treatment can increasingly be tailored to the individual rather than relying on a one-size-fits-all approach.
#GoodNews #ConstructiveJournalism #MentalHealth

